Theravance Bio: Q4 Earnings Snapshot
GEORGE TOWN, Cayman Islands (AP) — GEORGE TOWN, Cayman Islands (AP) — Theravance Biopharma Inc. (TBPH) on Monday reported a loss of $8.5 million in its fourth quarter.
On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of 17 cents. Earnings, adjusted for stock option expense and non-recurring costs, came to 3 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 4 cents per share.
The biopharmaceutical company posted revenue of $17.6 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $17.5 million.
For the year, the company reported a loss of $55.2 million, or $1 per share. Revenue was reported as $57.4 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH
